Mehalick David
- SEC CIK
- 0001846623
No open-market purchases or sales filed in the past year.
Current role at each company
- ZSQR Z Squared Inc.CEO and Presidentas of Feb 13, 2026
- COEP Coeptis Therapeutics Inc.CEO and Presidentas of Nov 18, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mehalick David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZSQR Z Squared Inc.
CEO and President1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2024 (view filing) | Jan 5-8 | 4 days | Mehalick DavidCEO and President | PPurchase | +25.1K | $0.6684 | +$16.7K | +0.9%2.78M after | 3 lots |
COEP Coeptis Therapeutics Inc.
CEO and President1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Mehalick DavidCEO and President | SSale | −1.20M | – | – | −40.0%1.80M after |